Toward Correlation in In Vivo and In Vitro Nanotoxicology Studies

Journal of Law, Medicine and Ethics

Volumn 40, Issue 4, 2012, Pages 795-801

  Maurer Jones, Melissa A ^a   Haynes, Christy L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOMATERIAL;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; DRUG APPROVAL; DRUG SCREENING; INHALATIONAL DRUG ADMINISTRATION; INJECTION; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; ORAL DRUG ADMINISTRATION; TOXICITY TESTING; UNITED STATES;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANIMALS; CELLS, CULTURED; DRUG APPROVAL; DRUG EVALUATION, PRECLINICAL; INJECTIONS; MODELS, BIOLOGICAL; NANOSTRUCTURES; TOXICITY TESTS; UNITED STATES;

EID: 84872168736     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2012.00707.x     Document Type: Article

References (38)

1. J. Xie, S. Lee, and X. Chen, "Nanoparticle-Based Theranostic Agents, " Advanced Drug Delivery Reviews 62, no. 11 (2010): 1064-1079.
2. Y.-S. Lin, K. R. Hurley, and C. L. Haynes, "Critical Considerations in the Biomedical Use of Mesoporous Silica Nanoparticles, " Journal of Physical Chemistry Letters 3, no. 3 (2012): 364-374.
3. M. L. Etheridge, S. A. Campbell, A. G. Erdman, C. L. Haynes, S. M. Wolf, and J. McCullough, "The Big Picture on Nanomedicine: The State of Investigational and Approved in Nanomedicine Products, " Nanomedicine: Nanotechnology, Biology, and Medicine (2012): in press.
4. A. C. von Escherbach, Nanotechnology: A Report of the U.S. Food and Drug Administration Nanotechnology Task Force ( Rockville, MD : U.S. Food and Drug Administration, 2007).
5. B. J. Marquis, M. A. Maurer-Jones, O. E. Ersin, Y.-S. Lin, and C. L. Haynes, "The Bench Scientist's Perspective on the Unique Considerations in Nanoparticle Regulation, " Journal of Nanoparticle Research 13, no. 4 (2011): 1389-1400.
6. B. J. Marquis, S. A. Love, K. L. Braun, and C. L. Haynes, "Analytical Methods to Assess Nanoparticle Toxicity, " Analyst 134, no. 3 (2009): 425-439; M. A. Maurer-Jones, K. C. Bantz, S. A. Love, B. J. Marquis, and C. L. Haynes, "Toxicity of Therapeutic Nanoparticles, "Nanomedicine 4, no. 2 (2009): 219-241; S. A. Love, M. A. Maurer-Jones, J. W. Thompson, Y.-S. Lin, and C. L. Haynes, "Assessing Nanoparticle Toxicity, "Annual Review of Analytical Chemistry 5 (2012): 181-205.
7. See Marquis et al., supra note 5.
8. Pari Pharma GmbH, "L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients, " U.S. National Institutes of Health, available at (last visited November 8, 2012).
9. M.D. Anderson Cancer Center, Aerosol l9-nc and Temozolomide in Ewing's Sarcoma, U.S. National Institutes of Health, available at (last visited November 8, 2012).
10. G. Oberdorster, V. Stone, and K. Donaldson, "Toxicology of Nanoparticles: A Historical Perspective, " Nanotoxicology 1, no. 1 (2007): 2-25.
11. See Love et al., supra note 6.
12. M. Horie, H. Fukui, K. Nishio, S. Endoh, H. Kato, K. Fujita, A. Miyauchi, A. Nakamura, M. Shichiri, N. Ishida, S. Kinugasa, Y. Morimoto, E. Niki, Y. Yoshida, and H. Iwahashi, "Evaluation of Acute Oxidative Stress Induced by Nio Nanoparticles In Vivo and In Vitro, " Journal of Occupational Health 53, no. 2 (2011): 64-74; D. B. Warheit, C. M. Sayes, and K. L. Reed, "Nanoscale and Fine Zinc Oxide Particles: Can In Vitro Assays Accurately Forecast Lung Hazards Following Inhalation Exposures?"Environmental Science and Technology 43, no. 20 (2009): 7939-7945; L. Tabet, C. Bussy, A. Setyan, A. Simon-Deckers, M. J. Rossi, J. Boczkowski, and S. Lanone, "Coating Carbon Nanotubes with a Polystyrene-Based Polymer Protects against Pulmonary Toxicity, "Particle and Fibre Toxicology 8 (2011): 3; E. K. Rushton, J. Jiang, S.S. Leonard, S. Eberly, V. Castranova, P. Biswas, A. Elder, X. Han, R. Gelein, J. Finkelstein and G. Oberdorster, "Concept of Assessing Nanoparticle Hazards Considering Nanoparticle Dosemetric and Chemical/Biological Response Metrics, "Journal of Toxicology and Environmental Health Part A, 73 (2010): 445-461.
13. See Horie et al., supra note 13.
14. See Warheit et al., supra note 13.
15. X. Wang, T. Xia, N. S. Addo, Z. Ji, S. Lin, H. Meng, C.-H. Chung, S. George, H. Zhang, M. Wang, N. Li, Y. Yang, V. Castranova, S. Mitra, J. Bonner, and A. Nel, "Dispersal State of Multiwalled Carbon Nanotubes Elicits Profibrogenic Cellular Responses That Correlate with Fibrogenesis Biomarkers and Fibrosis in the Murine Lung, " ACS Nano 5, no. 12 (2011): 9772-9787.
16. S.-A. Cryan, N. Sivadas, and L. Garcia-Contreras, "In Vivo Animal Models for Drug Delivery across the Lung Mucosal Barrier, " Advanced Drug Delivery Reviews 59, no. 11 (2007): 1133-1151.
17. See Love et al., supra note 6.
18. P. S. Melo, P. D. Marcato, S. C. Hubert, I. R. Ferreira, P. L. B. de, A. B. A. Almeida, N. Duran, S. Torsoni, A. B. Seabra, and O. L. Alves, "Nanoparticles in Treatment of Thermal Injured Rats: Is It Safe?" Journal of Physics: Conference Series 304, no. 1(2011): 012027/012021-012027/012028.
19. M. E. Samberg, S. J. Oldenburg, and N. A. Monteiro-Riviere, "Evaluation of Silver Nanoparticle Toxicity in Skin In Vivo and Keratinocytes In Vitro, " Environmental Health Perspectives 118, no. 3 (2010): 407-413.
20. A. R. Murray, E. Kisin, S. S. Leonard, S. H. Young, C. Kommineni, V. E. Kagan, V. Castranova, and A. A. Shvedova, "Oxidative Stress and Inflammatory Response in Dermal Toxicity of Single-Walled Carbon Nanotubes, " Toxicology 257, no. 3 (2009): 161-171.
21. Y.-H. Park, J. N. Kim, S. H. Jeong, J. E. Choi, S.-H. Lee, B. H. Choi, J. P. Lee, K. H. Sohn, K. L. Park, M-K. Kim, and S. W. Son, "Assessment of Dermal Toxicity of Nanosilica Using Cultured Keratinocytes, a Human Skin Equivalent Model and an In Vivo Model, " Toxicology 267, no. 1-3 (2010): 178-181.
22. C. J. Mbah, P. F. Uzor, and E. O. Omeje, "Perspectives on Transdermal Drug Delivery, " Journal of Chemical and Pharmaceutical Research 3, no. 3 (2011): 680-700.
23. A. Des Rieux, V. Fievez, M. Garinot, Y.-J. Schneider, and V. Preat, "Nanoparticles as Potential Oral Delivery Systems of Proteins and Vaccines: A Mechanistic Approach, " Journal of Controlled Release 116, no. 1 (2006): 1-27.
24. See Love et al., supra note 6.
25. G. J. Mahler, M. B. Esch, E. Tako, T. L. Southard, S. D. Archer, R. P. Glahn, and M. L. Shuler, "Oral Exposure to Polystyrene Nanoparticles Affects Iron Absorption, " Nature Nanotechnology 7, no. 4 (2012): 264-271.
26. B. Moulari, D. Pertuit, Y. Pellequer, and A. Lamprecht, "The Targeting of Surface Modified Silica Nanoparticles to Inflamed Tissue in Experimental Colitis, " Biomaterials 29, no. 34 (2008): 4554-4560.
27. A. K. Jain, N. K. Swarnakar, M. Das, C. Godugu, R. P. Singh, P. R. Rao, and S. Jain, "Augmented Anticancer Efficacy of Doxorubicin-Loaded Polymeric Nanoparticles after Oral Administration in a Breast Cancer Induced Animal Model, " Molecular Pharmaceutics 8, no. 4 (2011): 1140-1151.
28. See Etheridge et al., supra note 3.
29. See Love et al., supra note 6.
30. W. T. Al-Jamal, K. T. Al-Jamal, P. H. Bomans, P. M. Frederik, and K. Kostarelos, "Functionalized-Quantum-Dot-Liposome Hybrids as Multimodal Nanoparticles for Cancer, " Small 4, no. 9 (2008): 1406-1415; H. Devalapally, Z. Duan, M. V. Seiden, and M. M. Amiji, "Modulation of Drug Resistance in Ovarian Adenocarcinoma by Enhancing Intracellular Ceramide Using Tamoxifen-Loaded Biodegradable Polymeric Nanoparticles, "Clinical Cancer Research 14, no. 10 (2008): 3193-3203; C. J. Gannon, P. Cherukuri, B. I. Yakobson, L. Cognet, J. S. Kanzius, C. Kittrell, R. B. Weisman, M. Pasquali, H. K. Schmidt, R. E. Smalley, and S. A. Curley, "Carbon Nanotube-Enhanced Thermal Destruction of Cancer Cells in a Noninvasive Radiofrequency Field, "Cancer 110, no. 12 (2007): 2654-2665.
31. S. K. Singh, M. K. Singh, M. K. Nayak, S. Kumari, S. Shrivastava, J. J. A. Gracio, and D. Dash, "Thrombus Inducing Property of Atomically Thin Graphene Oxide Sheets, " ACS Nano 5, no. 6 (2011): 4987-4996.
32. See Marquis et al., supra note 5; A. D. Maynard, D. B. Warheit, and M. A. Philbert, "The New Toxicology of Sophisticated Materials: Nanotoxicology and Beyond, "Toxicological Sciences 120, no. S1 (2011): S109-S129.
33. See Lin et al., supra note 2.
34. M. Lundqvist, J. Stigler, G. Elia, I. Lynch, T. Cedervall, and K. A. Dawson, "Nanoparticle Size and Surface Properties Determine the Protein Corona with Possible Implications for Biological Impacts, " Proceedings of the National Academy of Sciences of the United States of America 105, no. 38 (2008): 14265-14270.
35. Y. S. Lin and C. L. Haynes, "Impacts of Mesoporous Silica Nanoparticle Size, Pore Ordering, and Pore Integrity on Hemolytic Activity, " Journal of the American Chemical Society 132, no. 13 (2010): 4834-4842.
36. L. A. A. Gilliam and D. K. St. Clair, "Chemotherapy-Induced Weakness and Fatigue in Skeletal Muscle: The Role of Oxidative Stress, " Antioxidant & Redox Signaling 15, no. 9 (2011): 2543-2563.
37. National Research Council, Toxicity Testing in the 21st Century: A Vision and a Strategy ( Washington, D.C. : National Academy Press, 2007).
38. See Maynard et al., supra note 36.